RayzeBio Common Stock Performance
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and RayzeBio Common are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days RayzeBio Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, RayzeBio Common is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 215.9 M | |
| Free Cash Flow | -90.7 M |
RayzeBio |
RayzeBio Common Relative Risk vs. Return Landscape
If you would invest (100.00) in RayzeBio Common Stock on October 6, 2025 and sell it today you would earn a total of 100.00 from holding RayzeBio Common Stock or generate -100.0% return on investment over 90 days. RayzeBio Common Stock is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than RayzeBio, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
RayzeBio Common Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for RayzeBio Common's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as RayzeBio Common Stock, and traders can use it to determine the average amount a RayzeBio Common's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| RYZB |
Based on monthly moving average RayzeBio Common is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of RayzeBio Common by adding RayzeBio Common to a well-diversified portfolio.
RayzeBio Common Fundamentals Growth
RayzeBio Stock prices reflect investors' perceptions of the future prospects and financial health of RayzeBio Common, and RayzeBio Common fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on RayzeBio Stock performance.
| Current Valuation | 3.19 B | |||
| Shares Outstanding | 60.02 M | |||
| Price To Book | 6.46 X | |||
| EBITDA | (73.86 M) | |||
| Total Debt | 10.57 M | |||
| Book Value Per Share | 9.62 X | |||
| Cash Flow From Operations | (56.05 M) | |||
| Earnings Per Share | (1.08) X | |||
| Total Asset | 324.78 M | |||
| Retained Earnings | (130.12 M) | |||
Things to note about RayzeBio Common Stock performance evaluation
Checking the ongoing alerts about RayzeBio Common for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for RayzeBio Common Stock help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| RayzeBio Common is not yet fully synchronised with the market data | |
| RayzeBio Common has some characteristics of a very speculative penny stock | |
| RayzeBio Common has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (63.5 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| RayzeBio Common generates negative cash flow from operations | |
| Over 90.0% of the company shares are owned by institutional investors |
- Analyzing RayzeBio Common's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether RayzeBio Common's stock is overvalued or undervalued compared to its peers.
- Examining RayzeBio Common's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating RayzeBio Common's management team can have a significant impact on its success or failure. Reviewing the track record and experience of RayzeBio Common's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of RayzeBio Common's stock. These opinions can provide insight into RayzeBio Common's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in RayzeBio Stock
If you are still planning to invest in RayzeBio Common Stock check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RayzeBio Common's history and understand the potential risks before investing.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |